Skip to main content
Ernst Lengyel, MD, Obstetrics & Gynecology, Chicago, IL, University of Chicago Medical Center

ErnstR.LengyelMDPhD

Obstetrics & Gynecology Chicago, IL

Gynecologic Oncology, Minimally Invasive / Endoscopic Surgery

Chairman and Professor Department of Obstetrics and Gynecology, University of Chicago Medicine

Overview of Dr. Lengyel

Dr. Lengyel is a Gynecologic Oncologist and Chair of the Department of Ob&Gyn at The University of Chicago. He received his M.D. from the University of Munich and trained in Munich, Stanford and at UCSF. He is board certified in Ob&Gyn and Gyn Oncology.
In addition to his clinical practice, Dr. Lengyel runs an ovarian cancer research laboratory, where he studies the biology of ovarian cancer metastasis and searches for novel drugs for treatment. Dr. Lengyel has an outstanding level of expertise and leadership in the surgical treatment of ovarian cancer and a deep commitment to improving women’s health in general.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Gynecologic Oncology, 2000 - 2003
  • Ludwig Maximilian University of Munich Faculty of Medicine
    Ludwig Maximilian University of Munich Faculty of MedicineClass of 1992

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2003 - 2026
  • CA State Medical License
    CA State Medical License 2003 - 2025
  • IN State Medical License
    IN State Medical License 2017 - 2025
  • American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

  • National Academy of Medicine National Academy, 2019
  • America's Top Doctors Castle Connolly, 2011-2016
  • Chicago Magazine: Top Doctors Castle Connolly, 2012, 2014
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A 3D Tumor Microenvironment Regulates Cell Proliferation, Peritoneal Growth and Expression Patterns  
    Ernst Lengyel, MD, ScienceDirect
  • m6A mRNA Methylation Regulates AKT Activity to Promote the Proliferation and Tumorigenicity of Endometrial Cancer  
    Ernst Lengyel, MD, Nature

Press Mentions

  • ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in Cancer
    ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
  • Upfront HIPEC May up Survival in Ovarian Cancer
    Upfront HIPEC May up Survival in Ovarian CancerAugust 25th, 2020
  • Accelerating Progress in Ovarian Cancer
    Accelerating Progress in Ovarian CancerAugust 16th, 2019
  • Join now to see all

Grant Support

  • Adaptation Of An Organotypic 3 Dimensional Culture For High-Throughput ScreeningNational Institute Of Neurological Disorders And Stroke2011
  • Regulation Of Adhesion And Proteolysis In Ovarian CancerNational Cancer Institute2006–2010

Professional Memberships

Other Languages

  • German

Hospital Affiliations

Insurance Accepted

  • Aetna Choice POS II
    Aetna HMO
    BCBS Blue Card PPO
    BCBS Illinois BlueChoice Select
    BCBS Illinois PPO
    CareFirst BCBS Maryland POS
    CareFirst BlueChoice Advantage
    CareFirst BlueChoice Network POS
    CareFirst BluePreferred PPO
    CIGNA HMO
    CIGNA Open Access
    CIGNA PPO
    Cofinity PPO
    Coventry Health Care PPO Platinum
    Coventry Missouri - HMO/POS
    First Health PPO
    Great West PPO
    HealthLink PPO
    Humana ChoiceCare Network PPO
    Multiplan PHCS PPO
    Multiplan PPO
    Sagamore Health Plus
    United Healthcare - Direct Choice Plus POS
    United Healthcare - Direct Options PPO
  • Please verify your coverage with the provider's office directly when scheduling an appointment